Cargando…
The Effect of Daily Iron Supplementation with 60 mg Ferrous Sulfate for 12 Weeks on Non-Transferrin Bound Iron Concentrations in Women with a High Prevalence of Hemoglobinopathies
There is a lack of evidence for the safety of untargeted daily iron supplementation in women, especially in countries such as Cambodia, where both anemia and hemoglobinopathies are common. Our aim was to assess serum non-transferrin bound iron (NTBI), a toxic biochemical that accumulates in blood wh...
Autores principales: | Steele, Shannon L., Kroeun, Hou, Karakochuk, Crystal D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406400/ https://www.ncbi.nlm.nih.gov/pubmed/30717475 http://dx.doi.org/10.3390/jcm8020180 |
Ejemplares similares
-
Daily Oral Supplementation with 60 mg of Elemental Iron for 12 Weeks Alters Blood Mitochondrial DNA Content, but Not Leukocyte Telomere Length in Cambodian Women
por: Steele, Shannon L., et al.
Publicado: (2021) -
Assessment of Acute Serum Iron, Non-Transferrin-Bound Iron, and Gastrointestinal Symptoms with 3-Week Consumption of Iron-Enriched Aspergillus oryzae Compared with Ferrous Sulfate
por: Bries, Amanda E, et al.
Publicado: (2019) -
The (Bio)Chemistry of Non-Transferrin-Bound Iron
por: Silva, André M. N., et al.
Publicado: (2022) -
Randomized Controlled Trial Comparing Ferrous Sulfate and Iron Sucrose in Iron Deficiency Anemia in Pregnancy
por: Chauhan, Neha, et al.
Publicado: (2023) -
Ferrous iron content of intravenous iron formulations
por: Gupta, Ajay, et al.
Publicado: (2016)